E
60 Degrees Pharmaceuticals, Inc. SXTP
$4.54 -$0.50-9.92% NASDAQ
Recommendation
Prev Close
$5.04
Volume
1,887,839
Avg Vol (90D)
2,239,164
Market Cap
$6.49M
Dividend & Yield
--
52-Week Range
$1.36 - $24.00
P/E (TTM)
--
EPS (TTM)
-$23.04
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Promising Small Cap Stocks To Consider - January 22nd
1/22/2026 - MarketBeat
Pharmaceutical Stocks To Consider - January 22nd
1/22/2026 - MarketBeat
60 Degrees Pharmaceuticals Soars After Runway Health Partnership
1/22/2026 - Benzinga
60 Degrees Pharmaceuticals Shares Surge 233% On Telehealth Partnership
1/22/2026 - RTT News - Momentum Stocks
Here's Why 60 Degrees Pharmaceuticals Stock (SXTP) Rocketed Today
1/22/2026 - TipRanks Financial Blog
60 Degrees Pharmaceuticals announces partnership with Runway Health
1/22/2026 - The Fly
60 Degrees Pharmaceuticals Announces Partnership with Runway Health to Provide International Travelers Direct Access to ARAKODA for Malaria Prevention
1/22/2026 - Globe Newswire
60 Degrees Pharmaceuticals Inc trading halted, news pending
1/17/2026 - TipRanks Financial Blog
60 Degrees Pharmaceuticals Inc trading halted, news pending
1/17/2026 - The Fly
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Shares Set to Reverse Split on Tuesday, January 20th
1/16/2026 - Ticker Report
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
1/15/2026 - GuruFocus
60 Degrees Pharmaceuticals announces approval of 1-for-4 reverse stock split
1/15/2026 - TipRanks Financial Blog
60 Degrees Pharmaceuticals announces approval of 1-for-4 reverse stock split
1/15/2026 - The Fly
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
1/15/2026 - Globe Newswire
60 Degrees Pharma outlines growth strategy in investor webinar
1/8/2026 - TipRanks Financial Blog
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients ...
12/29/2025 - GuruFocus
60 Degrees Pharmaceuticals (SXTP) Highlights Study Linking Babesia to Chronic Fatigue
12/29/2025 - GuruFocus
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Short Interest Up 80.9% in December
12/29/2025 - Ticker Report
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
12/29/2025 - Globe Newswire
Here's Why 60 Degrees Pharmaceuticals Inc. (SXTP) Looks Ripe for Bottom Fishing
12/23/2025 - Zacks Investment Research
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Stock Price Down 9.6% - Should You Sell?
12/20/2025 - Ticker Report
60 Degrees Pharmaceuticals (SXTP) Plans Expansion Following Sales Growth
12/11/2025 - GuruFocus
60 Degrees Pharmaceuticals expanding Arakoda sales and marketing in 2026
12/11/2025 - TipRanks Financial Blog
60 Degrees Pharmaceuticals expanding Arakoda sales and marketing in 2026
12/11/2025 - The Fly
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA Sales and Marketing in 2026
12/11/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
$1.35M
EBITDA (TTM)
-$7.84M
EBIT (TTM)
-$7.92M
Net Income (TTM)
-$7.97M
Balance Sheet
Total Assets (Q)
$6.69M
Total Debt (Q)
$153.80K
Total Liabilities (Q)
$2.34M
Book Value Per Share (Q)
-$5.01
Cash Flow
Cash from Operations (TTM)
-$6.79M
Cash from Investing (TTM)
$1.62M
Cash from Financing (TTM)
$5.98M
Net Change in Cash (TTM)
$815.00K
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
2.18
7-Day Total Return
113.77%
30-Day Total Return
17.22%
60-Day Total Return
-23.81%
90-Day Total Return
-17.69%
Year to Date Total Return
118.58%
1-Year Total Return
-74.34%
2-Year Total Return
-97.65%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Jan 14, 2026 - $1.36
52-week High
Jan 29, 2025 - $24.00
Valuation
Market Cap
$6.49M - Nano Cap
Enterprise Value
$12.01M
Price/Sales (TTM)
3.42
Price/Book (Q)
-1.01
Dividends and Shares
Shares Outstanding
918.90K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.60degreespharma.com
Phone Number
202 327 5422
Address
1025 Connecticut Avenue NW
Washington, DC 20036
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the... more
NASDAQ 01/23/2026 12:37PM Eastern Quotes delayed